AIG
ORIC icon

American International Group’s Oric Pharmaceuticals ORIC Stock Holding History

American International Group’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-19,236
Closed -$264K – 1890
2024
Q1 		$264K Sell
19,236
-165
-0.9% -$1.96K ﹤0.01% 1985
2023
Q4 		$178K Sell
19,401
-79
-0.4% -$571 ﹤0.01% 2229
2023
Q3 		$118K Buy
19,480
+693
+4% +$5.68K ﹤0.01% 2416
2023
Q2 		$146K Buy
+18,787
New +$107K ﹤0.01% 2350
2022
Q2 		– Sell
-15,697
Closed -$84K – 3217
2022
Q1 		$84K Sell
15,697
-1,105
-7% -$9.95K ﹤0.01% 2656
2021
Q4 		$247K Sell
16,802
-503
-3% -$7.84K ﹤0.01% 2248
2021
Q3 		$362K Buy
17,305
+771
+5% +$15.6K ﹤0.01% 2060
2021
Q2 		$292K Buy
16,534
+3,327
+25% +$72.9K ﹤0.01% 2269
2021
Q1 		$324K Buy
13,207
+309
+2% +$9.77K ﹤0.01% 2090
2020
Q4 		$437K Buy
12,898
+7,691
+148% +$221K ﹤0.01% 1829
2020
Q3 		$130K Sell
5,207
-118
-2% -$2.81K ﹤0.01% 2383
2020
Q2 		$180K Buy
+5,325
New +$170K ﹤0.01% 2186

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return
CG
Column Group San Francisco, California $88.1M AUM 148.03% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

American International Group's ORIC Position: Q2 2024 in Review

American International Group sold out of Oric Pharmaceuticals (ORIC) in Q2 2024, closing a stake of 19,236 shares — an estimated $264K sold.

American International Group first reported a position in ORIC in Q2 2020 and held it in 12 quarters. The position peaked at $437K in Q4 2020. 113 funds tracked by Wall St. Rank hold ORIC as of Q2 2024.

  • American International Group reported no remaining Oric Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 19,236 Oric Pharmaceuticals shares in Q2 2024, an estimated $264K.
  • American International Group first reported a position in Oric Pharmaceuticals in Q2 2020 and held it in 12 quarters.
  • American International Group's Oric Pharmaceuticals position peaked at $437K in Q4 2020.
  • 113 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.